1BARNES P J,ITO K,ADCOCK I M,et al.Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase.Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase[J].Lancet,2004,363(9410):731-733.
2PETER J,BARNE S.Theophylline,new perspectives for an old drug[J].American Journal of Respiratory and Critical Care Medicine,2003,167(6):813-818.
3BARALDO S,TURATO G,BADIN C,et al.Neutrophilic infiltration within the airway smooth muscle in patients with COPD[J].American Journal of Respiratory and Critical Care Medicine,2004,59(4):308-312.
4NEVIN B J,BRPADLEY K J.Comparative effects of inhaled budesonide and the NO-donating budesonide derivative,NCX 1020,against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge[J].Pulm Pharmacol Ther,2004,17(4):219-232.
5PLETZ M W,IOANS M,de ROUX A,et al.Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD[J].Eur Respir J,2004,23(4):532-537.
6SIN D D,LACY P,YORK E,et al.Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2004,167(11):24-31.
7GLUCK O,COLICE G.Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases [J].Chest,2004,125(5):1859-1876.
8PAPAIOANNOU W,PARKINSON N,FERKO L,et al.Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada[J].Osteoporosis International,2003,14(11):913-917.
9BLAIS L,BOURBEAU J,SHEEHY O,et al.Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment[J].Can Respir J,2004,11(1):27-32.
10SIN D D,GOLMOHAMMADI K,JACOBS P,et al.Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity[J].Am J Med,2004,116(5):325-331.
5Maltais F,Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial[J]. Am J Respir Crit Care Med, 2002,165 (5) :698-703.
6Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reative protein in patients with COPD, control smokers and non-smokers[J]. Thorax,2006,61(1) :23-28.
7Pubmed N, Almdal T. C-reative protain-- can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? [J]. Eur J Intern Med, 2006,17 (2) :88-91.
8Tobin MJ. Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transp lanta2tion, p leural disease, and lung cancer in AJRCCM 2002[J].Am J Respir Crit Care Med, 2003,167: 356-370.
